Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pennsylvania, USA.
Health Aff (Millwood). 2012 Apr;31(4):843-51. doi: 10.1377/hlthaff.2011.1181. Epub 2012 Mar 28.
There is tremendous interest in different approaches to slowing the rise in US per capita health spending. One approach is to publicly report on a provider's costs--also called efficiency, resource use, or value measures--with the hope that consumers will select lower-cost providers and providers will be encouraged to decrease spending. In this paper we explain why we believe that many current cost-profiling efforts are unlikely to have this intended effect. One of the reasons is that many consumers believe that more care is better and that higher-cost providers are higher-quality providers, so giving them information that some providers are lower cost may have the perverse effect of deterring them from accessing these providers. We suggest changes that can be made to content and design of public cost reports to increase the intended consumer and provider response.
人们对各种降低美国人均医疗支出增长的方法非常感兴趣。一种方法是公开报告提供者的成本——也称为效率、资源利用或价值衡量——希望消费者会选择成本较低的提供者,并且提供者会受到鼓励来减少支出。在本文中,我们解释了为什么我们认为许多当前的成本分析工作不太可能产生这种预期效果。其中一个原因是,许多消费者认为更多的治疗是更好的,而且成本更高的提供者是更高质量的提供者,因此向他们提供一些提供者成本较低的信息可能会产生相反的效果,阻止他们使用这些提供者。我们建议对公共成本报告的内容和设计进行修改,以增加预期的消费者和提供者的反应。